Go
View All
Topical Ophthalmic Agents (Selected List)
Topical Testosterone Formulations and Recommended Daily Doses
Total Body Water (as Percentage of Body Weight) in Relation to Age and Sex
Traditional Criteria for the Classification of SLE. (A Patient is Classified as Having SLE if Any 4 or More of Criteria are Met.)
Treatment Choices for Cancers Responsive to Systemic Agents (Listed in Alphabetical Order)
Treatment of African Trypanosomiasis
Treatment of AIDS-Related Opportunistic Infections and Malignancies (Listed in Alphabetical Order)
Treatment of Anaerobic Intra-Abdominal Infections
Treatment of Bleeding in Selected Inherited Disorders of Hemostasis
Treatment of Common Skin and Soft Tissue Infections (SSTIs)
Treatment of E Histolytica Amebiasis
Treatment of Hyperkalemia
Treatment of Hypertensive Emergency Depending on Primary Site of End-Organ Damage. See Table 3-8 for Dosages
Treatment of Lyme Disease
Treatment of Malaria
Treatment of Multiple Sclerosis (in Alphabetical Order Within Categories)
Treatment Options for Peptic Ulcer Disease
Two Sample Low-Dose Initiation Protocols
Typical Clinical Manifestations of Large-, Medium-, and Small-Vessel Vasculitis
Typical Csf Findings in Various Cns Diseases (Listed in Alphabetical Order after Normal)
Ulcerative Colitis: Assessment of Disease Activity
Uncommon Allergic and Pseudoallergic Conditions
Useful Topical Dermatologic Therapeutic Agents
Use of the Osmol Gap in Toxicology
Vitamin D Preparations Used in the Treatment of Hypoparathyroidism
Warfarin Dosing Adjustment Guidelines for Initiation of Warfarin Therapy
Warfarin-Dosing Adjustment Guidelines for Patients Receiving Long-Term Therapy, with Target INR 2-3
WHO Classification of Lymphomas (Modified from 2022 Version)
WHO Classification of Myeloid Neoplasms (Modified)
WHO Recommendations for the Treatment of Uncomplicated Falciparum Malaria
Displaying items 421 - 450 of 451